@article{4bdfe17f293747a3b8ac8d2dd8da3ff3,
title = "Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas",
abstract = "Knowledge of the clinical efficacy in recurrent neuroendocrine carcinomas is sparse. Treatment with temozolomide alone or in combination with capecitabine and bevacizumab has recently shown promising results.",
author = "Olsen, {Ingrid Marie Holst} and S{\o}rensen, {Jens B} and Birgitte Federspiel and Andreas Kjaer and Hansen, {Carsten P} and Ulrich Knigge and Langer, {Seppo W}",
year = "2012",
doi = "10.1100/2012/170496",
language = "English",
volume = "2012",
pages = "170496",
journal = "The Scientific World Journal",
issn = "2356-6140",
publisher = "Hindawi Publishing Corporation",
}